Trial intelligence / Profile preview

PROGIS: EC-MPS in Renal Transplant Patients with GI Symptoms

NCT00150007Phase 4Completed

Sponsor
Novartis
Start
Jun 2004
Primary completion
Jun 2005
01

Overview

Phase 4, open-label trial of mycophenolate sodium in kidney transplantation, sponsored by Novartis. Started Jun 2004; status: completed.

02

Drugs

mycophenolate sodium
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT00150007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00150007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call